Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseases
Abstract Purpose Radioiodine has been used for the treatment of benign thyroid diseases for over 70 years. However, internationally, there is no common standard for pretherapeutic dosimetry to optimally define the individual therapy activity. Here, we analyze how absorbed tissue doses are influenced...
Main Authors: | Jochen Hammes, Lutz van Heek, Melanie Hohberg, Manuel Reifegerst, Simone Stockter, Markus Dietlein, Markus Wild, Alexander Drzezga, Matthias Schmidt, Carsten Kobe |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-12-01
|
Series: | EJNMMI Physics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40658-018-0231-x |
Similar Items
-
A practical approach on radioprotection in the treatment of radioiodine for thyroid cancer
by: Janaína Dutra Silvestre Mendes, et al.
Published: (2018-09-01) -
Improved Patient Dosimetry at Radioiodine Therapy by Combining the ICRP Compartment Model and the EANM Pre-Therapeutic Standard Procedure for Benign Thyroid Diseases
by: Martin Andersson, et al.
Published: (2021-03-01) -
Radioiodine Refractory Follicular Thyroid Cancer and Surgery for Cervical Relapse
by: Costanza Chiapponi, et al.
Published: (2021-12-01) -
Radioiodine-resistant metastases of well-differentiated thyroid cancer, analysis of tumor characteristics and primary surgical intervention
by: M. V. Ostafiychuk, et al.
Published: (2021-10-01) -
Potential of the drug-regulation iodide uptake in patients for prevention of radioiodine-refractory papillary thyroid cancer
by: Dmitriy Kirillovich Fomin, et al.
Published: (2014-11-01)